OJRA  Vol.4 No.1 , February 2014
Two Approaches to the Study of a Controversial Relationship: Cutaneous Photosensitivity and Anti-Ro/SS-A Autoantibodies
Abstract: Background: Autoantibodies (Aabs) are the hallmark of numerous systemic autoimmune pathologies (SAPs), for instance anti-Ro/SS-A Aabs are usually found in Systemic Lupus Erythematosus (SLE) and Sjogren’s Syndrome. Cutaneous photosensitivity (CP) is found in most forms and subsets of LE and consists of a skin rash as a result of unusual reaction to sunlight. There are many theories which relate specifically the presence of circulating anti-Ro/SS-A Aabs with the CP phenomenon, though there are several studies which are in disagreement. Results: In this study we analyzed the relationship between CP and anti-Ro Aabs by means of two approaches. The first one included an in vitro model where we evaluated by flow cytometry the binding capacity of affinity-purified Aabs to autoantigens relocalized on apoptotic keratinocyte’s surface. We found that there was no relationship between the binding capacity of serum from 10 selected patients or their corresponding purified anti-Ro52 and anti-Ro60 Aabs, and the presence or absence of CP, neither with the SAPs. The in vivo model consisted of Hairless SKH:1 mice which were induced to produce anti-murine Ro52 and/or Ro60 Aabs and were subsequently irradiated with UVB light. We evaluated the skin histology and also the epidermal production of TNF-α. We found no differences between the groups in neither of the parameters evaluated. Conclusions: These results agree with some studies on the role of the Aabs in CP, considering anti-Ro Aabs not as the only responsible for the manifestation; and disagree with many other authors, who believe in the strong association between these two events.
Cite this paper: M. L. Paz, E. M. Cela, A. Ferrari, A. D. Friedrich, J. Leoni and D. Maglio, "Two Approaches to the Study of a Controversial Relationship: Cutaneous Photosensitivity and Anti-Ro/SS-A Autoantibodies," Open Journal of Rheumatology and Autoimmune Diseases, Vol. 4 No. 1, 2014, pp. 1-12. doi: 10.4236/ojra.2014.41001.

[1]   A. J. Wysenbeek, D. A. Block and J. F. Fries, “Prevalence and Expression of Photosensitivity in Systemic Lupus Erythematosus,” Annals of the Rheumatic Diseases, Vol. 48, No. 6, 1989, pp. 461-463.

[2]   N. Scheinfeld and V. A. Deleo, “Photosensitivity in Lupus Erythematosus,” Photodermatology, Photoimmunology & Photomedicine, Vol. 20, No. 5, 2004, pp. 272-279.

[3]   M. C. Hochberg, “Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus,” Arthritis & Rheumatology, Vol. 40, No. 9, 1997, p. 1725.

[4]   J. Wenzel, S. Zahn and T. Tuting, “Pathogenesis of Cutaneous Lupus Erythematosus: Common and Different Features in Distinct Subsets,” Lupus, Vol. 19, No. 9, 2010, pp. 1020-1028.

[5]   R. D. Sontheimer, “Photoimmunology of Lupus Erythematosus and Dermatomyositis: A Speculative Review,” Photochemistry and Photobiology, Vol. 63, No. 5, 1996, pp. 583-594.

[6]   T. P. Millard, J. L. Hawk and J. M. McGregor, “Photo-sensitivity in Lupus,” Lupus, Vol. 9, No. 1, 2000, pp. 3-10.

[7]   F. Furukawa, “Photosensitivity in Cutaneous Lupus Erythematosus: Lessons from Mice and Men,” Journal of Dermatological Science, Vol. 33, No. 2, 2003, pp. 81-89.

[8]   G. Fabini, S. A. Rutjes, C. Zimmermann, G. J. Pruijn and G. Steiner, “Analysis of the Molecular Composition of Ro Ribonucleoprotein Complexes. Identification of Novel Y RNA-Binding Proteins,” European Journal of Biochemistry, Vol. 267, No. 9, 2000, pp. 2778-2789.

[9]   M. Herrmann, R. E. Voll and J. R. Kalden, “Etiopathogenesis of Systemic Lupus Erythematosus,” Immunology Today, Vol. 21, No. 9, 2000, pp. 424-426.

[10]   M. Reichlin and R. Scofield, “SS-A (Ro) Autoantibodies,” In: J. Peter and Y. Shoenfeld, Eds., Autoantibodies, Elsevier, Amsterdam, 1996, pp. 783-788.

[11]   C. A. von Muhlen and E. M. Tan, “Autoantibodies in the Diagnosis of Systemic Rheumatic Diseases,” Seminars in Arthritis and Rheumatism, Vol. 24, No. 5, 1995, pp. 323-358.

[12]   S. E. Sonesson, S. Salomonsson, L. A. Jacobsson, K. Bremme and M. Wahren-Herlenius, “Signs of First-Degree Heart Block Occur in One-Third of Fetuses of Pregnant Women with Anti-SSA/Ro 52-kd Antibodies,” Arthritis & Rheumatology, Vol. 50, No. 4, 2004, pp. 1253-1261.

[13]   K. Tsuzaka, T. Fujii, M. Akizuki, T. Mimori, T. Tojo, et al., “Clinical Significance of Antibodies to Native or Denatured 60-kd or 52-kd Ro/SS-A Proteins in Sjogren’s Syndrome,” Arthritis & Rheumatology, Vol. 37, No. 1, 1994, pp. 88-92.

[14]   L. D. Heinlen, M. T. McClain, L. L. Ritterhouse, B. F. Bruner, C. C. Edgerton, et al., “60 kD Ro and nRNP A Frequently Initiate Human Lupus Autoimmunity,” PLoS One, Vol. 5, No. 3, 2010, p. e9599.

[15]   L. Casciola-Rosen, G. Anhalt and A. Rosen, “Autoantigens Targeted in Systemic Lupus Erythematosus Are Clustered in Two Populations of Surface Structures on Apoptotic Keratinocytes,” Journal of Experimental Medicine, Vol. 179, No. 4, 1994, pp. 1317-1330.

[16]   K. Ayukawa, S. Taniguchi, J. Masumoto, S. Hashimoto, H. Sarvotham, et al., “La Autoantigen Is Cleaved in the COOH Terminus and Loses the Nuclear Localization Signal during Apoptosis,” Journal of Biological Chemistry, Vol. 275, No. 44, 2000, pp. 34465-34470.

[17]   D. Mevorach, J. L. Zhou, X. Song and K. B. Elkon, “Systemic Exposure to Irradiated Apoptotic Cells Induces Autoantibody Production,” Journal of Experimental Medicine, Vol. 188, No. 2, 1998, pp. 387-392.

[18]   F. Furukawa, T. Itoh, H. Wakita, H. Yagi, Y. Tokura, et al., “Keratinocytes from Patients with Lupus Erythematosus Show Enhanced Cytotoxicity to Ultraviolet Radiation and to Antibody-Mediated Cytotoxicity,” Clinical & Experimental Immunology, Vol. 118, No. 1, 1999, pp. 164-170.

[19]   F. Furukawa, M. Kashihara-Sawami, M. B. Lyons and D. A. Norris, “Binding of Antibodies to the Extractable Nuclear Antigens SS-A/Ro and SS-B/La Is Induced on the Surface of Human Keratinocytes by Ultraviolet Light (UVL): Implications for the Pathogenesis of Photosensitive Cutaneous Lupus,” Journal of Investigative Dermatology, Vol. 94, No. 1, 1990, pp. 77-85.

[20]   T. D. Golan, K. B. Elkon, A. E. Gharavi and J. G. Krueger, “Enhanced Membrane Binding of Autoantibodies to Cultured Keratinocytes of Systemic Lupus Erythematosus Patients after Ultraviolet B/Ultraviolet A Irradiation,” Journal of Clinical Investigation, Vol. 90, No. 3, 1992, pp. 1067-1076.

[21]   F. Furukawa, “Antinuclear Antibody-Keratinocyte Interactions in Photosensitive Cutaneous Lupus Erythematosus,” Histology and Histopathology, Vol. 14, No. 2, 1999, pp. 627-633.

[22]   P. G. Sutej, A. J. Gear, R. C. Morrison, M. Tikly, M. de Beer, et al., “Photosensitivity and Anti-Ro (SS-A) Antibodies in Black Patients with Systemic Lupus Erythematosus (SLE),” British Journal of Rheumatology, Vol. 28, No. 4, 1989, pp. 321-324.

[23]   C. J. Sanders, H. Van Weelden, G. A. Kazzaz, V. Sigurdsson, J. Toonstra, et al., “Photosensitivity in Patients with Lupus Erythematosus: A Clinical and Photobiological Study of 100 Patients Using a Prolonged Phototest Protocol,” British Journal of Dermatology, Vol. 149, No. 1, 2003, pp. 131-137.

[24]   M. L. Paz, D. H. Gonzalez Maglio, M. Pino, A. Ferrari, F. S. Weill, et al., “Anti-Ribonucleoproteins Autoantibodies in Patients with Systemic Autoimmune Diseases. Relation with Cutaneous Photosensitivity,” Clinical Rheumatology, Vol. 30, No. 2, 2011, pp. 209-216.

[25]   K. Yamamoto, “Pathogenesis of Sjogren’s Syndrome,” Autoimmunity Reviews, Vol. 2, No. 1, 2003, pp. 13-18.

[26]   N. Nardi, P. Brito-Zeron, M. Ramos-Casals, S. Aguilo, R. Cervera, et al., “Circulating Auto-Antibodies against Nuclear and Non-Nuclear Antigens in Primary Sjogren’s Syndrome: Prevalence and Clinical Significance in 335 Patients,” Clinical Rheumatology, Vol. 25, No. 3, 2006, pp. 341-346.

[27]   A. Doria, C. Biasinutto, A. Ghirardello, E. Sartori, R. Rondinone, et al., “Photosensitivity in Systemic Lupus Erythematosus: Laboratory Testing of ARA/ACR Definition,” Lupus, Vol. 5, No. 4, 1996, pp. 263-268.

[28]   D. Ioannides, B. D. Golden, J. P. Buyon ans J. C. Bystryn, “Expression of SS-A/Ro and SS-B/La Antigens in Skin Biopsy Specimens of Patients with Photosensitive Forms of Lupus Erythematosus,” Archives of Dermatology, Vol. 136, No. 3, 2000, pp. 340-346.

[29]   F. Furukawa, H. Kanauchi and S. Imamura, “Susceptibility to UVB Light in Cultured Keratinocytes of Cutaneous Lupus Erythematosus,” Dermatology, Vol. 189, Suppl. 1, 1994, pp. 18-23.

[30]   L. A. Lee, K. K. Gaither, S. N. Coulter, D. A. Norris and J. B. Harley, “Pattern of Cutaneous Immunoglobulin G Deposition in Subacute Cutaneous Lupus Erythematosus Is Reproduced by Infusing Purified Anti-Ro (SSA) Autoantibodies into Human Skin-Grafted Mice,” Journal of Clinical Investigation, Vol. 83, No. 5, 1989, pp. 1556-1562.

[31]   T. L. Davis, C. B. Lyde, B. M. Davis and R. D. Sontheimer, “Perturbation of Experimental Ultraviolet light-Induced Erythema by Passive Transfer of Serum from Subacute Cutaneous Lupus Erythematosus Patients,” Journal of Investigative Dermatology, Vol. 92, No. 4, 1989, pp. 573-577.

[32]   I. Maczynska, B. Millo, V. Ratajczak-Stefanska, R. Maleszka, Z. Szych, et al., “Proinflammatory Cytokine (IL-1beta, IL-6, IL-12, IL-18 and TNF-Alpha) Levels in Sera of Patients with Subacute Cutaneous Lupus Erythematosus (SCLE),” Immunology Letters, Vol. 102, No. 1, 2006, pp. 79-82.

[33]   C. H. Orteu, R. D. Sontheimer and J. P. Dutz, “The Pathophysiology of Photosensitivity in Lupus Erythematosus,” Photodermatology, Photoimmunology & Photomedicine, Vol. 17, No. 3, 2001, pp. 95-113.

[34]   S. Louhimies, “Directive 86/609/EEC on the Protection of Animals Used for Experimental and Other Scientific Purposes,” Alternatives to Laboratory Animals, Vol. 30, Suppl. 2, 2002, pp. 217-219.

[35]   P. Boukamp, R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, et al., “Normal Keratinization in a Spontaneously Immortalized Aneuploid Human Keratinocyte Cell Line,” Journal of Cell Biology, Vol. 106, No. 3, 1988, pp. 761-771.

[36]   M. L. Paz, A. Ferrari, F. S. Weill, J. Leoni and D. H. Maglio, “Time-Course Evaluation and Treatment of Skin Inflammatory Immune Response after Ultraviolet B Irradiation,” Cytokine, Vol. 44, No. 1, 2008, pp. 70-77.

[37]   M. L. Paz, D. H. Gonzalez Maglio, F. S. Weill, J. Bustamante and J. Leoni, “Mitochondrial Dysfunction and Cellular Stress Progression after Ultraviolet B Irradiation in Human Keratinocytes,” Photodermatology, Photoimmunology & Photomedicine, Vol. 24, No. 3, 2008, pp. 115-122.

[38]   M. Reichlin, M. Rader and J. B. Harley, “Autoimmune Response to the Ro/SSA Particle Is Directed to the Human Antigen,” Clinical & Experimental Immunology, Vol. 76, No. 3, 1989, pp. 373-377.

[39]   D. H. Gonzalez Maglio, M. L. Paz, A. Ferrari, F. S. Weill, A. Czerniczyniec, et al., “Skin Damage and Mitochondrial Dysfunction after Acute Ultraviolet B Irradiation: Relationship with Nitric Oxide Production,” Photodermatology, Photoimmunology & Photomedicine, Vol. 21, No. 6, 2005, pp. 311-317.

[40]   Y. S. Yang, M. C. Yang, B. Wang and J. C. Weissler, “Autoantigen Ro52 Directly Interacts with Human IgG Heavy Chain in Vivo in Mammalian Cells,” Molecular Immunology, Vol. 37, No. 10, 2000, pp. 591-602.

[41]   M. Takahata, M. Bohgaki, T. Tsukiyama, T. Kondo, M. Asaka, et al., “Ro52 Functionally Interacts with IgG1 and Regulates Its Quality Control via the ERAD System,” Molecular Immunology, Vol. 45, No. 7, 2008, pp. 2045-2054.

[42]   F. Furukawa and M. Muto, “Ethnic Differences in Immunogenetic Features and Photosensitivity of Cutaneous Lupus Erythematosus,” Archives of Dermatological Research, Vol. 301, No. 1, 2009, pp. 111-115.

[43]   K. H. Ching, P. D. Burbelo, C. Tipton, C. Wei, M. Petri, et al., “Two Major Autoantibody Clusters in Systemic Lupus Erythematosus,” PLoS One, Vol. 7, No. 2, 2012, Article ID: e32001.

[44]   C. L. Keech, T. P. Gordon and J. McCluskey, “Structural Differences between the Human and Mouse 52-kD Ro Autoantigens Associated with Poorly Conserved Autoantibody Activity across Species,” Clinical & Experimental Immunology, Vol. 104, No. 2, 1996, pp. 255-263.

[45]   M. Wahren, K. Skarstein, I. Blange, I. Pettersson and R. Jonsson, “MRL/lpr Mice Produce Anti-Ro 52,000 MW Antibodies: Detection, Analysis of Specificity and Site of Production,” Immunology, Vol. 83, No. 1, 1994, pp. 9-15.

[46]   U. S. Deshmukh, J. E. Lewis, F. Gaskin, C. C. Kannapell, S. T. Waters, et al., “Immune Responses to Ro60 and Its Peptides in Mice. I. The Nature of the Immunogen and Endogenous Autoantigen Determine the Specificities of the Induced Autoantibodies,” Journal of Experimental Medicine, Vol. 189, No. 3, 1999, pp. 531-540.

[47]   F. Topfer, T. Gordon and J. McCluskey, “Intra-and Intermolecular Spreading of Autoimmunity Involving the Nuclear Self-Antigens La (SS-B) and Ro (SS-A),” Proceedings of the National Academy of Sciences of the United States of America, Vol. 92, No. 3, 1995, pp. 875-879.